Display options
Cite
Rattanasompattikul M, Molnar MZ, Lee ML, et al. Anti-Inflammatory and Anti-Oxidative Nutrition in Hypoalbuminemic Dialysis Patients (AIONID) study: results of the pilot-feasibility, double-blind, randomized, placebo-controlled trial. J Cachexia Sarcopenia Muscle. 2013;4(4):247-57doi: 10.1007/s13539-013-0115-9.
Rattanasompattikul, M., Molnar, M. Z., Lee, M. L., Dukkipati, R., Bross, R., Jing, J., Kim, Y., Voss, A. C., Benner, D., Feroze, U., Macdougall, I. C., Tayek, J. A., Norris, K. C., Kopple, J. D., Unruh, M., Kovesdy, C. P., & Kalantar-Zadeh, K. (2013). Anti-Inflammatory and Anti-Oxidative Nutrition in Hypoalbuminemic Dialysis Patients (AIONID) study: results of the pilot-feasibility, double-blind, randomized, placebo-controlled trial. Journal of cachexia, sarcopenia and muscle, 4(4), 247-57. https://doi.org/10.1007/s13539-013-0115-9
Rattanasompattikul, Manoch, et al. "Anti-Inflammatory and Anti-Oxidative Nutrition in Hypoalbuminemic Dialysis Patients (AIONID) study: results of the pilot-feasibility, double-blind, randomized, placebo-controlled trial." Journal of cachexia, sarcopenia and muscle vol. 4,4 (2013): 247-57. doi: https://doi.org/10.1007/s13539-013-0115-9
Rattanasompattikul M, Molnar MZ, Lee ML, Dukkipati R, Bross R, Jing J, Kim Y, Voss AC, Benner D, Feroze U, Macdougall IC, Tayek JA, Norris KC, Kopple JD, Unruh M, Kovesdy CP, Kalantar-Zadeh K. Anti-Inflammatory and Anti-Oxidative Nutrition in Hypoalbuminemic Dialysis Patients (AIONID) study: results of the pilot-feasibility, double-blind, randomized, placebo-controlled trial. J Cachexia Sarcopenia Muscle. 2013 Dec;4(4):247-57. doi: 10.1007/s13539-013-0115-9. Epub 2013 Sep 20. PMID: 24052226; PMCID: PMC3830006.
Copy Download .nbib Format: NLM
Share it on

J Cachexia Sarcopenia Muscle. 2013 Dec;4(4):247-57. doi: 10.1007/s13539-013-0115-9. Epub 2013 Sep 20.

Anti-Inflammatory and Anti-Oxidative Nutrition in Hypoalbuminemic Dialysis Patients (AIONID) study: results of the pilot-feasibility, double-blind, randomized, placebo-controlled trial.

Journal of cachexia, sarcopenia and muscle

Manoch Rattanasompattikul, Miklos Z Molnar, Martin L Lee, Ramanath Dukkipati, Rachelle Bross, Jennie Jing, Youngmee Kim, Anne C Voss, Debbie Benner, Usama Feroze, Iain C Macdougall, John A Tayek, Keith C Norris, Joel D Kopple, Mark Unruh, Csaba P Kovesdy, Kamyar Kalantar-Zadeh

Affiliations

  1. Harold Simmons Center for Kidney Disease Research & Epidemiology, Division of Nephrology and Hypertension, University of California Irvine Medical Center, Orange, CA, USA.

PMID: 24052226 PMCID: PMC3830006 DOI: 10.1007/s13539-013-0115-9

Abstract

BACKGROUND: Low serum albumin is common and associated with protein-energy wasting, inflammation, and poor outcomes in maintenance hemodialysis (MHD) patients. We hypothesized that in-center (in dialysis clinic) provision of high-protein oral nutrition supplements (ONS) tailored for MHD patients combined with anti-oxidants and anti-inflammatory ingredients with or without an anti-inflammatory appetite stimulator (pentoxifylline, PTX) is well tolerated and can improve serum albumin concentration.

METHODS: Between January 2008 and June 2010, 84 adult hypoalbuminemic (albumin <4.0 g/dL) MHD outpatients were double-blindly randomized to receive 16 weeks of interventions including ONS, PTX, ONS with PTX, or placebos. Nutritional and inflammatory markers were compared between the four groups.

RESULTS: Out of 84 subjects (mean ± SD; age, 59 ± 12 years; vintage, 34 ± 34 months), 32 % were Blacks, 54 % females, and 68 % diabetics. ONS, PTX, ONS plus PTX, and placebo were associated with an average change in serum albumin of +0.21 (P = 0.004), +0.14 (P = 0.008), +0.18 (P = 0.001), and +0.03 g/dL (P = 0.59), respectively. No related serious adverse events were observed. In a predetermined intention-to-treat regression analysis modeling post-trial serum albumin as a function of pre-trial albumin and the three different interventions (ref = placebo), only ONS without PTX was associated with a significant albumin rise (+0.17 ± 0.07 g/dL, P = 0.018).

CONCLUSIONS: In this pilot-feasibility, 2 × 2 factorial, placebo-controlled trial, daily intake of a CKD-specific high-protein ONS with anti-inflammatory and anti-oxidative ingredients for up to 16 weeks was well tolerated and associated with slight but significant increase in serum albumin levels. Larger long-term controlled trials to examine hard outcomes are indicated.

References

  1. Semin Nephrol. 2009 Jan;29(1):3-14 - PubMed
  2. J Ren Nutr. 2009 Sep;19(5):412-21 - PubMed
  3. Nephrol Dial Transplant. 2001 Oct;16(10):1968-71 - PubMed
  4. Nephrol Dial Transplant. 2002;17 Suppl 11:28-31 - PubMed
  5. J Am Soc Nephrol. 2002 Jan;13 Suppl 1:S28-36 - PubMed
  6. Nat Rev Nephrol. 2010 Jan;6(1):15-7 - PubMed
  7. Am J Transplant. 2011 May;11(5):1006-15 - PubMed
  8. Nat Rev Nephrol. 2011 May 31;7(7):369-84 - PubMed
  9. JAMA. 2011 Oct 12;306(14):1574-81 - PubMed
  10. Am J Kidney Dis. 2003 Nov;42(5):864-81 - PubMed
  11. Am J Kidney Dis. 2002 Feb;39(2):274-82 - PubMed
  12. J Ren Nutr. 2009 Mar;19(2):127-35 - PubMed
  13. J Am Soc Nephrol. 2010 Feb;21(2):223-30 - PubMed
  14. Am J Kidney Dis. 2011 Sep;58(3):418-28 - PubMed
  15. Crit Care Med. 1999 Sep;27(9):1908-15 - PubMed
  16. Kidney Int. 2002 Jun;61(6):2240-9 - PubMed
  17. Nurs Res. 1993 Sep-Oct;42(5):287-9 - PubMed
  18. Nephrol Dial Transplant. 2002 Sep;17(9):1684-8 - PubMed
  19. Annu Rev Immunol. 1989;7:625-55 - PubMed
  20. J Cachexia Sarcopenia Muscle. 2010 Dec;1(2):135-145 - PubMed
  21. Am J Kidney Dis. 2001 Dec;38(6):1343-50 - PubMed
  22. Kidney Int. 1999 May;55(5):1899-911 - PubMed
  23. J Ren Nutr. 2005 Jan;15(1):39-43 - PubMed
  24. Am J Clin Nutr. 2004 Aug;80(2):299-307 - PubMed
  25. J Am Soc Nephrol. 2006 Nov;17(11):3149-57 - PubMed
  26. Acta Cardiol. 2002 Jun;57(3):197-204 - PubMed
  27. Curr Opin Clin Nutr Metab Care. 2005 Jul;8(4):388-96 - PubMed
  28. Biochem J. 1998 Nov 15;336 ( Pt 1):57-62 - PubMed
  29. Clin Nutr. 1998 Dec;17(6):265-71 - PubMed
  30. Semin Dial. 2005 Sep-Oct;18(5):365-9 - PubMed
  31. Adv Ren Replace Ther. 2003 Jul;10(3):155-69 - PubMed
  32. Am J Physiol Regul Integr Comp Physiol. 2004 Oct;287(4):R801-8 - PubMed
  33. Am J Clin Nutr. 2009 Aug;90(2):407-14 - PubMed
  34. Kidney Int. 2002 Sep;62(3):1054-9 - PubMed
  35. Hemodial Int. 2006 Oct;10(4):315-25 - PubMed
  36. J Cachexia Sarcopenia Muscle. 2011 Mar;2(1):9-25 - PubMed
  37. Am J Kidney Dis. 2011 Jul;58(1):101-8 - PubMed
  38. Am J Clin Nutr. 2000 Aug;72(2):355-60 - PubMed
  39. Kidney Int. 2008 Feb;73(4):391-8 - PubMed
  40. Am J Kidney Dis. 2009 Feb;53(2):298-309 - PubMed
  41. J Ren Nutr. 1998 Jan;8(1):25-33 - PubMed
  42. N Engl J Med. 2002 Nov 14;347(20):1557-65 - PubMed
  43. Crit Care Med. 2003 Feb;31(2):491-500 - PubMed
  44. Am J Kidney Dis. 2005 Sep;46(3):387-405 - PubMed
  45. Perit Dial Int. 2001;21 Suppl 3:S157-62 - PubMed
  46. Nephrol Dial Transplant. 2000 Jul;15(7):953-60 - PubMed
  47. J Ren Nutr. 2005 Jul;15(3):318-31 - PubMed
  48. Blood Purif. 2001;19(2):143-51 - PubMed

Publication Types

Grant support